-The Hindu Moratorium on Intellectual Property Complaints Switzerland and the U.S. have begun a campaign at the World Trade Organisation (WTO) to not renew a moratorium on ‘non-violation complaints and situations’ for intellectual property rights that expires at the end of the year. Intellectual property laws are governed internationally by the Trade-Related Intellectual Property Rights (TRIPS) Agreement. The moratorium first came into being in 1995, when the WTO was born. And has survived...
More »SEARCH RESULT
Total Matching Records found : 326
TB, diabetes drug prices to fall by 30% -Sushmi Dey
-The Times of India NEW DELHI: The drug price regulator has capped prices of 30 medicines including antibiotics and those used in treatment of diabetes, tuberculosis and malaria. The move is expected to bring down prices of most of these medicines by 25-30%. However, in some cases the reduction could be by as much as 50%. The National Pharmaceutical Pricing Authority (NPPA), which has the mandate to regulate prices of essential medicines,...
More »Pharma Patents after 10 Years
-Economic and Political Weekly Ten years on, the progressive provisions of the amended Indian Patents Act are being watered down. Ten years have passed since the Indian Patents Act, 1970 was amended in 2005 to bring the country’s laws in line with the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). The most important of the 2005 amendments was the introduction of product patents for 20 years, including for pharmaceutical products,...
More »US pushes for new IP laws to help Big Pharma at cost of poor; NDA says Yes Boss -Paranjoy Guha Thakurta
-CurrentNews.in ‘Make in India' an empty slogan; Govt promotes ‘Sell in India' The government of the USA is pushing India to revise its existing robust Intellectual Property (IP) framework that effectively protects the national and public interest by balancing the rights of IP owners with their obligation to society. Submitting to the US agenda will adversely impact innovation, production and prices, especially of medicines and medical care. Multinational Pharmaceutical Companies will reap...
More »Chemists will have to mention in bill whether drug is price controlled -Sushmi Dey
-The Times of India NEW DELHI: In an attempt to empower consumers and save them from paying more for medicines, the government is set to make it mandatory for chemists to mention in the bill whether they are selling a price-controlled product or not. Besides, the bill will also mention the price of the medicine as capped by the government. The move will enable a consumer to make an informed choice while...
More »
